Heppenheimer
Well-Known Member
Back to COVID...
I wrote a few days ago that I thought molnuparivir (the oral COVID medication that Merck submitted to the FDA for EAU) would be more of a useful additional tool, than the game-changer that it's being touted as.
I've changed my opinion. Hospitals across the country right now are struggling with staffing issues, particularly nursing. The role for molnuparivir is essentially the same as the monoclonal antibody infusions we've been using in an attempt to keep people out of the hospital. The infusions, though, are very labor intensive from a nursing working hours perspective. Most health care organizations only have a limited ability to give outpatient infusions for any indication (cancer treatment centers being an exception), much less all the COVID-19 cases we've dealt with over the past year. Having an oral medication that a patient can easily take in the comfort of their own home will free up a whole lot of resources now tied down giving the monoclonal antibody infusions.
So, if the FDA gives the go-ahead, molnuparivir could take quite a bit of pressure off of many over-burdened hospitals.
And I still say Disney should mix it in their Dole Whip dispensers..
I wrote a few days ago that I thought molnuparivir (the oral COVID medication that Merck submitted to the FDA for EAU) would be more of a useful additional tool, than the game-changer that it's being touted as.
I've changed my opinion. Hospitals across the country right now are struggling with staffing issues, particularly nursing. The role for molnuparivir is essentially the same as the monoclonal antibody infusions we've been using in an attempt to keep people out of the hospital. The infusions, though, are very labor intensive from a nursing working hours perspective. Most health care organizations only have a limited ability to give outpatient infusions for any indication (cancer treatment centers being an exception), much less all the COVID-19 cases we've dealt with over the past year. Having an oral medication that a patient can easily take in the comfort of their own home will free up a whole lot of resources now tied down giving the monoclonal antibody infusions.
So, if the FDA gives the go-ahead, molnuparivir could take quite a bit of pressure off of many over-burdened hospitals.
And I still say Disney should mix it in their Dole Whip dispensers..
Last edited: